Scott Sabish
Family · Concord, NHNPI 1497128680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 406 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Viiv Healthcare Company at 39.2% of the total. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 406 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Merck$537
- Johnson & Johnson$472
- AbbVie$382
- Novo Nordisk$249
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$791%
- Food & beverage$7,95297%
- Education$1722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 153 | $3,212 |
| Gilead | 111 | $2,086 |
| Merck | 24 | $537 |
| Johnson & Johnson | 29 | $472 |
| AbbVie | 17 | $382 |
| Novo Nordisk | 12 | $249 |
| EMD Serono, Inc. | 10 | $198 |
| Boehringer Ingelheim | 9 | $185 |
| Janssen Products, LP | 2 | $172 |
| Amgen | 7 | $125 |
| Napo Pharmaceuticals Inc | 7 | $113 |
| Lilly USA, LLC | 6 | $99 |
| AstraZeneca | 6 | $92 |
| Lucid Diagnostics Inc. | 2 | $75 |
| Medtronic | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $34 |
| Dexcom, Inc. | 1 | $26 |
| Novartis | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| Abbott | 1 | $17 |
| Bayer | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,203 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $351 |
| Omeprazole | 12 | $170 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $148 |
| Atorvastatin Calcium | 12 | $72 |
| Lisinopril | 15 | $46 |
| Losartan Potassium | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other family in Concord
- Brant OliverConcord$9K
- Christine KociszewskiConcord$4K
- Emely QuinonesConcord$3K
- Pamela MeyerConcord$2K
- Amy KennedyConcord$2K
- Julie LaplanteConcord$2K
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Summer BellDerry$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.